Impact of interval and combination therapies on the management of actinic keratosis: review and clinical considerations (Q33596422)

28 July 2017

1 reference

title

Impact of interval and combination therapies on the management of actinic keratosis: review and clinical considerations (English)

1 reference

28 July 2017

1 reference

1 reference

George M Martin

1

1 reference

28 July 2017

8 June 2010

1 reference

Journal of Dermatological Treatment

28 July 2017

1 reference

28 July 2017

22

1 reference

28 July 2017

5

1 reference

28 July 2017

288-297

1 reference

Time trends and familial risks in squamous cell carcinoma of the skin.

28 July 2017

1 reference

https://api.crossref.org/works/10.3109%2F09546631003797072

The epidemiology of skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546631003797072

Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546631003797072

Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis").

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546631003797072

Malignant transformation of solar keratoses to squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546631003797072

The majority of cutaneous squamous cell carcinomas arise in actinic keratoses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546631003797072

The risk of progression to invasive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546631003797072

Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546631003797072

Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546631003797072

Twice daily vs. four times daily 5-fluorouracil therapy for actinic keratoses: a split face study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546631003797072

Efficacy of imiquimod as an adjunct to cryotherapy for actinic keratoses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546631003797072

Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546631003797072

Placebo-controlled, double-blind, randomized pilot study of imiquimod 5% cream applied once per week for 6 months for the treatment of actinic keratoses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546631003797072

A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546631003797072

Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546631003797072

A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546631003797072

Weekly pulse dosing: effective and comfortable topical 5-fluorouracil treatment of multiple facial actinic keratoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546631003797072

Does intermittent "pulse" topical 5-fluorouracil therapy allow destruction of actinic keratoses without significant inflammation?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546631003797072

Cycle therapy of actinic keratoses of the face and scalp with 5% topical imiquimod cream: An open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546631003797072

A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546631003797072

Treatment of photodamaged skin with trichloroacetic acid and topical tretinoin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546631003797072

Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546631003797072

Retinoids in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546631003797072

10.3109/09546631003797072

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

20528483